Cargando…
SARS-CoV-2 Antibodies Mediate Complement and Cellular Driven Inflammation
The ongoing pandemic of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to constitute a serious public health threat worldwide. Protective antibody-mediated viral neutralization in response to SARS-CoV-2 infection has been firm...
Autores principales: | Jarlhelt, Ida, Nielsen, Sif Kaas, Jahn, Camilla Xenia Holtermann, Hansen, Cecilie Bo, Pérez-Alós, Laura, Rosbjerg, Anne, Bayarri-Olmos, Rafael, Skjoedt, Mikkel-Ole, Garred, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596567/ https://www.ncbi.nlm.nih.gov/pubmed/34804055 http://dx.doi.org/10.3389/fimmu.2021.767981 |
Ejemplares similares
-
Lectin Pathway Enzyme MASP-2 and Downstream Complement Activation in COVID-19
por: Götz, Maximilian Peter, et al.
Publicado: (2022) -
Functional Analysis of a Novel Complement C5a Receptor 1-Blocking Monoclonal Antibody
por: Cyranka, Leon, et al.
Publicado: (2023) -
Chimeric Proteins Containing MAP-1 and Functional Domains of C4b-Binding Protein Reveal Strong Complement Inhibitory Capacities
por: Hertz, Cecilie E., et al.
Publicado: (2018) -
The SARS-CoV-2 Y453F mink variant displays a pronounced increase in ACE-2 affinity but does not challenge antibody neutralization
por: Bayarri-Olmos, Rafael, et al.
Publicado: (2021) -
Reply to Lassaunière: On the functional characterization of the Y453F RBD variant found in cluster 5 SARS-CoV-2
por: Bayarri-Olmos, Rafael, et al.
Publicado: (2021)